Building Accessible Over-Ear ANC Experiences: QCY's Vision Reflected Through H3S
HONG KONG, Jan. 29, 2026 /PRNewswire/ -- QCY has introduced H3S, the latest update to its H3 over-ear headphone series, reinforcing the brand's commitment to making advanced noise-canceling audio more accessible to everyday users. Building on the...
DORCO Wins 2025 GOOD DESIGN® Award; Global Traction Continues for the Flagship Razor
Following GOOD DESIGN® recognition, early sales momentum and consumer adoption underscore DORCO's global flagship product SEOUL, South Korea, Jan. 29, 2026 /PRNewswire/ -- DORCO, South Korea's leading shaving brand, today announced that its flagship...
Bedsure Expands Offline Retail Footprint With Launch of Its GentleSoft® Ribbed Plush Blanket In Targets Nationwide
The brand's softest blanket is now available for shoppers to experience in person as Bedsure leans into offline growth NEW YORK, Jan. 29, 2026 /PRNewswire/ -- Bedsure, a leading home textile brand trusted by millions worldwide, is expanding its...
Cheche Group Announces Strategic Cooperation with Volkswagen DSSO and Cardif Airstar Insurance to Build Digital Insurance System with Intelligent Pricing Model
BEIJING, Jan. 29, 2026 /PRNewswire/ -- Cheche Group Inc. (NASDAQ: CCG) ("Cheche" or the "Company"), China's leading auto insurance technology platform, today announced that Volkswagen (Anhui) Digital Sales and Services Co., Ltd. ("DSSO"), Beijing...
Annual Pet Event "Pet Show 2026" Opens Today
Nearly 1,000 Booths Gathered Ancient Egypt and Mantis-Themed Zones Create a Pet-and-People Carnival HONG KONG, Jan. 29, 2026 /PRNewswire/ -- Organized by Exhibition Group, Hong Kong's largest public pet exhibition, the "Pet Show 2026" (the Show),...
Saudi Arabia Unveils Ambitious New Privatization Strategy to Expand Public-Private Partnerships
Strategy sets out 220+ new public-private partnerships contracts by 2030 Targets initial $64 billion (SAR 240 billion) in direct capex investment Broadens private sector participation across new and existing projects National Privatization Strategy...
MicuRx Announces FDA Clearance of IND Application to Proceed to Phase 2a Trial of MRX-5 in Patients with Mycobacterium abscessus Pulmonary Disease
FOSTER CITY, Calif., Jan. 29, 2026 /PRNewswire/ -- MicuRx Pharmaceuticals, Inc. ("MicuRx"), a clinical-stage biopharmaceutical company focused on developing novel anti-infective therapies for drug-resistant bacterial infections, recently announced...
XtalPi Convenes Global Experts to Shape the Future of Molecular Glue Drug Discovery: From Serendipity to Precision
Global thought leaders presented cutting-edge research at the 2026 International Symposium on Molecular Glue Drug Discovery. XtalPi unveils the AI-driven XGlue™ platform to enable rapid, closed-loop molecular glue drug discovery. Cross-sector...